(Reuters) - A panel of independent advisers to the U.S. Food and Drug Administration is set to meet on April 6 to discuss considerations for use of CO.
(Reuters) - A panel of independent advisers to the U.S. Food and Drug Administration is set to meet on April 6 to discuss considerations for use of CO.
(Reuters) - A panel of independent advisers to the U.S. Food and Drug Administration is set to meet on April 6 to discuss considerations for use of CO.
(Reuters) -The U.S. drug regulator said on Monday a panel of independent advisers will meet on April 6 to discuss considerations for use of COVID-19 v.